Cargando…
Author Correction: Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro
Autores principales: | Toft-Bertelsen, Trine Lisberg, Jeppesen, Mads Gravers, Tzortzini, Eva, Xue, Kai, Giller, Karin, Becker, Stefan, Mujezinovic, Amer, Bentzen, Bo Hjorth, Andreas, Loren B., Kolocouris, Antonios, Kledal, Thomas Nitschke, Rosenkilde, Mette Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661827/ https://www.ncbi.nlm.nih.gov/pubmed/34893762 http://dx.doi.org/10.1038/s42003-021-02940-2 |
Ejemplares similares
-
Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro
por: Toft-Bertelsen, Trine Lisberg, et al.
Publicado: (2021) -
Reply to: How Many SARS-CoV-2 “Viroporins” Are Really Ion Channels?
por: Toft-Bertelsen, Trine L., et al.
Publicado: (2022) -
Publisher Correction: Reply to: How many SARS-CoV-2 “viroporins” are really ion channels?
por: Toft-Bertelsen, Trine L., et al.
Publicado: (2022) -
Amantadine for COVID-19 treatment (ACT study): a randomized, double-blinded, placebo-controlled clinical trial
por: Weis, Nina, et al.
Publicado: (2023) -
Molecular Biophysics of Class A G Protein Coupled Receptors–Lipids Interactome at a Glance—Highlights from the A(2A) Adenosine Receptor
por: Tzortzini, Efpraxia, et al.
Publicado: (2023)